Anti RIPK2 pAb (ATL-HPA015273)

Atlas Antibodies

Catalog No.: ATL-HPA015273-25

Protein Description: receptor-interacting serine-threonine kinase 2
Gene Name: RIPK2
Alternative Gene Name: CARD3, CARDIAK, RICK, RIP2
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000041135: 73%, ENSRNOG00000009389: 73%
Entrez Gene ID: 8767
Uniprot ID: O43353
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, ICC, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: LPAPQDNDFLSRKAQDCYFMKLHHCPGNHSWDSTISGSQRAAFCDHKTTPCSSAIINPLSTAGNSERLQPGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTKPTRTSKVRQLLDTTDIQGEEFAKVI
• Gene Sequence: LPAPQDNDFLSRKAQDCYFMKLHHCPGNHSWDSTISGSQRAAFCDHKTTPCSSAIINPLSTAGNSERLQPGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTKPTRTSKVRQLLDTTDIQGEEFAKVI
• Gene ID - Mouse: ENSMUSG00000041135
• Gene ID - Rat: ENSRNOG00000009389
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti RIPK2 pAb (ATL-HPA015273) – 3 Found

Flebbe, Hannah; Hamdan, Feda H; Kari, Vijayalakshmi; Kitz, Julia; Gaedcke, Jochen; Ghadimi, B Michael; Johnsen, Steven A; Grade, Marian. Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer. Cancers. 2019;11(8) 

Groeger, S; Denter, F; Lochnit, G; Schmitz, M L; Meyle, J. Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism. Infection And Immunity. 2020;88(5) 

Yan, Yiwu; Zhou, Bo; Qian, Chen; Vasquez, Alex; Kamra, Mohini; Chatterjee, Avradip; Lee, Yeon-Joo; Yuan, Xiaopu; Ellis, Leigh; Di Vizio, Dolores; Posadas, Edwin M; Kyprianou, Natasha; Knudsen, Beatrice S; Shah, Kavita; Murali, Ramachandran; Gertych, Arkadiusz; You, Sungyong; Freeman, Michael R; Yang, Wei. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis. Nature Communications. 2022;13(1):669.